Physician

Ravinder Gandhi, M.D.

According to 2025 Medicare claims, Ravinder Gandhi, M.D. (NPI: 1003995689) practices pulmonary disease in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is RAVINDER GANDHI, M.D., P.C. (NPI: 1699846360; TIN: 383315062) and primary practice location at 48192-4668.

Gandhi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 557 traditional Medicare patients, billed 5,349 HCPCS/CPT codes, and received $440,101 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,157 prescription claims across 524 beneficiaries totaling $1,548,345 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 3,083 claims. Open Payments data shows 63 records totaling $1,266. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $223,067 to $1,548,345. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $89,474 to $210,859.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	767	5,228	$462,990
2016	848	6,035	$510,320
2017	798	5,475	$449,788
2018	975	6,190	$525,397
2019	951	5,869	$468,244
2020	836	4,617	$371,428
2021	882	5,197	$444,801
2022	749	5,864	$482,556
2023	610	5,320	$421,211
2024	557	5,349	$440,101

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	213	1,102	$223,067
2016	262	1,377	$216,347
2017	288	1,605	$252,417
2018	414	2,397	$475,684
2019	478	3,112	$787,074
2020	507	3,705	$1,315,459
2021	482	3,321	$1,305,341
2022	462	2,962	$1,437,599
2023	486	2,971	$1,373,323
2024	524	3,157	$1,548,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	276	1,441	$130,763
2016	454	1,984	$164,955
2017	613	2,453	$149,230
2018	846	2,876	$168,062
2019	1,103	3,631	$211,062
2020	1,034	3,948	$284,346
2021	926	3,853	$331,688
2022	841	3,453	$284,709
2023	820	3,364	$271,222
2024	777	3,083	$261,844

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	255	333	$141
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	259	2,321	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	262	486	$96
94729	Test to examine how well the lungs exchange gases	200	206	$41
94060	Test to measure expiratory airflow and volume changes before and after medication administration	219	238	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	29	870	$376,862
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	396	16,320	$331,824
Dupixent Pen	Dupilumab	58	1,722	$232,775
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	161	5,610	$112,441
Breo Ellipta	Fluticasone/Vilanterol	137	4,950	$64,372

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	12	92	$92,151
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	70	531	$39,797
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	44	$33,464
E1392	Portable oxygen concentrator, rental	Y	46	373	$12,534
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	12	$12,247

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	63	$1,266	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ravinder Gandhi, M.D.?

Tedicare shows public-source Medicare data for Ravinder Gandhi, M.D. (NPI 1003995689), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ravinder Gandhi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ravinder Gandhi, M.D.?

Ravinder Gandhi, M.D. is linked to RAVINDER GANDHI, M.D., P.C. (billing NPI 1699846360) in the available physician profile data.

Does Ravinder Gandhi, M.D. have Open Payments data?

Ravinder Gandhi, M.D. has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.